SURG vs IDT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 18, 2026

SURG

51.3
AI Score
VS
SURG Wins

IDT

39.6
AI Score

Investment Advisor Scores

SURG

51score
Recommendation
HOLD

IDT

40score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric SURG IDT Winner
Forward P/E 15.1515 12.0482 IDT
PEG Ratio 0.5333 1.415 SURG
Revenue Growth 40.7% 7.1% SURG
Earnings Growth -77.7% 30.0% IDT
Tradestie Score 51.3/100 39.6/100 SURG
Profit Margin -47.9% 6.7% IDT
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

SURG 1M: -21.2% · 3M: -61.3% IDT 1M: +16.8% · 3M: +28.0%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.8%), weak momentum, RSI 34

RSI (14): 33.5 · Price: $0.12

IDT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.4% over 20 days), RSI 66

RSI (14): 66.0 · Price: $80.67

Fundamentals Snapshot

Metric SURG IDT
Market Cap — —
Forward P/E 12.4 18.1
Trailing P/E — 23.9
Revenue (TTM) — —
Revenue Growth 0.4% 0.1%
Gross Margin -0.2% 0.4%
Operating Margin 0.2% 0.1%
EPS -1.50 3.44
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.